News
31 August 2023
HHS’s Recommendation to Reschedule Cannabis to Schedule III: A European Venture Capital Fund’s Perspective
The US Department of Health and Human Services (HHS) recently recommended that cannabis be rescheduled from a Schedule…
7 October 2022
GUEST POST: Harvard Medical School
A guest post from the Harvard Medical School on the Endocannabinoid System
4 April 2022
PODCAST: The UK Cannabis Investment Landscape
Canverse and Oskare Capital discuss the UK Cannabis Investment Landscape
17 February 2022
A Better Way to Invest in Cannabis
Private Market Placements vs Stock Market Investing
31 January 2022
Oskare Capital Overview
A brief overview of Oskare Capital's European medical and pharma cannabis fund
5 May 2021
Óskare Capital Webinar – The Endocannabinoid System
ÓSKARE CAPITAL's first Webinar focusses on the Endocannabinoid System (ECS) and the science behind the fund’s investment thesis.